ISG15 and immune diseases - PubMed (original) (raw)
Review
ISG15 and immune diseases
Young Joo Jeon et al. Biochim Biophys Acta. 2010 May.
Abstract
ISG15, the product of interferon (IFN)-stimulated gene 15, is the first identified ubiquitin-like protein, consisting of two ubiquitin-like domains. ISG15 is synthesized as a precursor in certain mammals and, therefore, needs to be processed to expose the C-terminal glycine residue before conjugation to target proteins. A set of three-step cascade enzymes, an E1 enzyme (UBE1L), an E2 enzyme (UbcH8), and one of several E3 ligases (e.g., EFP and HERC5), catalyzes ISG15 conjugation (ISGylation) of a specific protein. These enzymes are unique among the cascade enzymes for ubiquitin and other ubiquitin-like proteins in that all of them are induced by type I IFNs or other stimuli, such as exposure to viruses and lipopolysaccharide. Mass spectrometric analysis has led to the identification of several hundreds of candidate proteins that can be conjugated by ISG15. Some of them are type I IFN-induced proteins, such as PKR and RIG-I, and some are the key regulators that are involved in IFN signaling, such as JAK1 and STAT1, implicating the role of ISG15 and its conjugates in type I IFN-mediated innate immune responses. However, relatively little is known about the functional significance of ISG15 induction due to the lack of information on the consequences of its conjugation to target proteins. Here, we describe the recent progress made in exploring the biological function of ISG15 and its reversible modification of target proteins and thus in their implication in immune diseases.
Copyright 2010 Elsevier B.V. All rights reserved.
Figures
Fig. 1
Protein modification by ISG15. ISG15-specific proteases cleave off the C-terminal extensions from ISG15 precursors to generate matured ISG15 molecules. ISG15 is activated by UBE1L (E1) at the expense of ATP and is subsequently linked to the activating enzyme via thiosester bond. ISG15 linked to UBE1L is transferred to UbcH8 (E2) and then to a target protein with the aid of an ISG15 E3 ligase, such as EFP and HERC5. UBP43 functions in the reversal of the ISGylation process by cleaving off ISG15 molecules that are conjugated to the substrate proteins via isopeptide bonds.
Fig. 2
Comparison of the amino acid sequence of ISG15 with that of ubiquitin and FAT10. (A) The amino acid sequences of ubiquitin, ISG15, and FAT10 are aligned. Similar amino acids are indicated by dark blue and the identical amino acids are by light blue. (B) Schematic diagram shows the N- and C-terminal ubiquitin-like domains that are flanked by a flexible linker region containing a Pro residue. (C) The amino acid sequences of ISG15 from various species are aligned. Note that ISG15 molecules from human, mouse, and rat have the C-terminal extensions of 5–8 amino acids, whereas ISG15 molecules from bovine and fish do not.
Fig. 3
Comparison of the tertiary structure of ISG15 with that of ubiquitin. (A) ISG15 alone. (B) Ubiquitin alone. (C) Ubiquitin is overlapped to the N- and C-terminal domains of ISG15. (D) All of ubiquitin and the N- and C-terminal domains of ISG15 are overlapped. Information for structures was from the protein data bank (PDB): ubiquitin from UCH-L3-Ub complex (PDB code: 1XD3) and ISG15 (PDB code: 1Z2M). The photographic images were made by using the PyMol program.
Fig. 4
Viral immune-evading proteins. NS3/4A is involved in the cleavage of IPS-1, thus blocking the RIG-I signaling for IRF-3-mediated induction of type I IFN as well as of ISG15. NS1B inhibits the thioesterification of UBE1L and thereby the generation of ISG15 conjugates that are required for antiviral response. PLpro, OTU protease, and viral E3 protein mediate the removal of ISG15 from its conjugates.
Similar articles
- Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells.
Dastur A, Beaudenon S, Kelley M, Krug RM, Huibregtse JM. Dastur A, et al. J Biol Chem. 2006 Feb 17;281(7):4334-8. doi: 10.1074/jbc.M512830200. Epub 2005 Dec 28. J Biol Chem. 2006. PMID: 16407192 - The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein.
Zhao C, Beaudenon SL, Kelley ML, Waddell MB, Yuan W, Schulman BA, Huibregtse JM, Krug RM. Zhao C, et al. Proc Natl Acad Sci U S A. 2004 May 18;101(20):7578-82. doi: 10.1073/pnas.0402528101. Epub 2004 May 6. Proc Natl Acad Sci U S A. 2004. PMID: 15131269 Free PMC article. - The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase.
Zou W, Zhang DE. Zou W, et al. J Biol Chem. 2006 Feb 17;281(7):3989-94. doi: 10.1074/jbc.M510787200. Epub 2005 Dec 13. J Biol Chem. 2006. PMID: 16352599 - [Advances in ubiquitin-like protein ISG15-mediated anti-viral response].
Zhu ZX, Wei JC, Shi ZX, Wu KB, Ma ZY. Zhu ZX, et al. Bing Du Xue Bao. 2012 Jan;28(1):78-83. Bing Du Xue Bao. 2012. PMID: 22416355 Review. Chinese. - Coronaviral PLpro proteases and the immunomodulatory roles of conjugated versus free Interferon Stimulated Gene product-15 (ISG15).
Gold IM, Reis N, Glaser F, Glickman MH. Gold IM, et al. Semin Cell Dev Biol. 2022 Dec;132:16-26. doi: 10.1016/j.semcdb.2022.06.005. Epub 2022 Jun 25. Semin Cell Dev Biol. 2022. PMID: 35764457 Free PMC article. Review.
Cited by
- The Ubiquitin Tale: Current Strategies and Future Challenges.
Upadhyay A, Joshi V. Upadhyay A, et al. ACS Pharmacol Transl Sci. 2024 Sep 4;7(9):2573-2587. doi: 10.1021/acsptsci.4c00278. eCollection 2024 Sep 13. ACS Pharmacol Transl Sci. 2024. PMID: 39296276 Review. - Machine learning-based analysis of Ebola virus' impact on gene expression in nonhuman primates.
Rezapour M, Niazi MKK, Lu H, Narayanan A, Gurcan MN. Rezapour M, et al. Front Artif Intell. 2024 Aug 30;7:1405332. doi: 10.3389/frai.2024.1405332. eCollection 2024. Front Artif Intell. 2024. PMID: 39282474 Free PMC article. - Inhibitory effects of senkyuchachosan on SARS-CoV-2 papain-like protease activity in vitro.
Kiba Y, Tanikawa T, Hayashi T, Yokogawa T, Sano A, Suzuki R, Kitamura M. Kiba Y, et al. J Nat Med. 2024 Jun;78(3):784-791. doi: 10.1007/s11418-024-01788-0. Epub 2024 Mar 21. J Nat Med. 2024. PMID: 38512650 - Single-cell profiling of peripheral blood and muscle cells reveals inflammatory features of juvenile dermatomyositis.
Chen X, Lian D, Zeng H. Chen X, et al. Front Cell Dev Biol. 2023 Apr 20;11:1166017. doi: 10.3389/fcell.2023.1166017. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37152289 Free PMC article. - Emerging roles of interferon-stimulated gene-15 in age-related telomere attrition, the DNA damage response, and cardiovascular disease.
González-Amor M, Dorado B, Andrés V. González-Amor M, et al. Front Cell Dev Biol. 2023 Mar 21;11:1128594. doi: 10.3389/fcell.2023.1128594. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37025175 Free PMC article. Review.
References
- Isaacs A., Lindenmann J. Virus interference: I. The interferon. Proc. R. Soc. Lond. B Biol. Sci. 1957;147:258–267. - PubMed
- Darnell J.E., Jr., Kerr I.M., Stark G.R. Jak–STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415–1421. - PubMed
- Heim M.H., Kerr I.M., Stark G.R., Darnell J.E., Jr. Contribution of STAT SH2 groups to specific interferon signaling by the Jak–STAT pathway. Science. 1995;267:1347–1349. - PubMed
- Shuai K., Stark G.R., Kerr I.M., Darnell J.E., Jr. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science. 1993;261:1744–1746. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous